Pilot and Feasibility Grant (alpha-1 antitrypsin deficiency)
The Pilot and Feasibility Grant funded by the Alpha-1 Foundation support researchers working on alpha-1 antitrypsin (AAT) expression, and the pathogenesis/management of AAT deficiency. The proposed project should generate new hypotheses and/or new methods in research areas relevant to AAT deficiency. Applicants may apply for up to 75,000 USD over 1 year (no indirect costs). This is an annual award and the next letters of intent are due September 30, 2022 and invited full applications are due February 17, 2023.
Sign in with your free account to see important eligibility criteria, including research location, citizenship, legal working rights and deadline/s.